As Aurora kinase B is a mitotic kinase that regulates chromosome segregation and cell cycle progression during mitosis, dual treatment with a SMO inhibitor and Aurora B/C kinase inhibitor might target both ciliated and mitotic tumor cells. This evidence concerns the gene AURKB and neoplasm.